Gaughan, W J <br/><br/>
A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  Oct 1997 
 - 495-500 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0272-6386 
<br/><br/><label>Standard No.: </label>10.1016/s0272-6386(97)90307-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anabolic Agents--administration & dosage<br/>Anemia--drug therapy<br/>Drug Therapy, Combination<br/>Epoetin Alfa<br/>Erythropoietin--administration & dosage<br/>Female<br/>Hematocrit<br/>Humans<br/>Kidney Failure, Chronic--complications<br/>Male<br/>Middle Aged<br/>Nandrolone--administration & dosage<br/>Nandrolone Decanoate<br/>Prospective Studies<br/>Recombinant Proteins<br/>Renal Dialysis<br/>Time Factors